Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-11-001575
Filing Date
2011-03-16
Accepted
2011-03-16 17:04:13
Documents
13
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K unigene_10k-123110.htm 10-K 1935121
2 EXHIBIT 3.2 ex3-2.htm EX-3.2 11228
3 EXHIBIT 10.8 ex10-8.htm EX-10.8 11367
4 EXHIBIT 10.38 ex10-38.htm EX-10.38 540940
5 EXHIBIT 10.66 ex10-66.htm EX-10.66 56358
6 EXHIBIT 10.67 ex10-67.htm EX-10.67 22012
7 EXHIBIT 23.1 ex23-1.htm EX-23.1 3822
8 EXHIBIT 23.2 ex23-2.htm EX-23.2 13701
9 EXHIBIT 31.1 ex31-1.htm EX-31.1 16860
10 EXHIBIT 31.2 ex31-2.htm EX-31.2 17539
11 EXHIBIT 32.1 ex32-1.htm EX-32.1 6202
12 EXHIBIT 32.2 ex32-2.htm EX-32.2 6262
13 chart.jpg GRAPHIC 57936
  Complete submission text file 0001437749-11-001575.txt   2722326
Mailing Address 81 FULTON STREET BOONTON NJ 07005
Business Address 81 FULTON STREET BOONTON NJ 07005 973-265-1100
UNIGENE LABORATORIES INC (Filer) CIK: 0000352747 (see all company filings)

EIN.: 222328609 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-16005 | Film No.: 11692619
SIC: 2833 Medicinal Chemicals & Botanical Products